Formulation optimization and drug release in vitro of membrane controlled tablets of puerarin inclusion compound
E Zhang, Rui Tan, Jian Ping Gu, Lili He, Feng Yao
Abstract
E Zhang, Rui Tan, Jian Ping Gu, Lili He, Feng Yao
Abstract
OBJECTIVE: To prepare membrane controlled tablets of puerarin sinclusion compound and to investigate the drug release in vitro. METHOD: The single factors affecting drug release in vitro were investigated. Then, uniform design was used to optimize the formulation of controlled osmotic-pump tablets. RESULT: Drug release profiles in vitro were affected obviously by membrane thickness, penetrating agents and porogen. CONCLUSION: Membrane controlled tablets of puerarin inclusion compound were prepared according to the optimal formulation with zero-order kinetics.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To prepare membrane controlled tablets of puerarin sinclusion compound and to investigate the drug release in vitro. METHOD: The single factors affecting drug release in vitro were investigated. Then, uniform design was used to optimize the formulation of controlled osmotic-pump tablets. RESULT: Drug release profiles in vitro were affected obviously by membrane thickness, penetrating agents and porogen. CONCLUSION: Membrane controlled tablets of puerarin inclusion compound were prepared according to the optimal formulation with zero-order kinetics.
Key concepts: Puerarin, In vitro, Membrane, Drug, Chromatography, Chemistry, Controlled release, Pharmacology